Developer docs
API playgroundTry for free, no card

Search company profiles

AngioConsult

Full company profile

uuid000owku

Namestring
AngioConsult
Legal namestring
AngioConsult GmbH
Websiteurl
angioconsult.de
Company typeenum
Private
Founded yearint
2001
Descriptiontext

AngioConsult GmbH is a privately held healthcare consulting firm headquartered in Speyer, Germany, founded in 2001. The firm specializes in guiding medical device and healthcare innovation companies from concept through commercialization, with a particular focus on the cardiovascular, structural heart, vascular surgery, and radiology/angiology verticals. AngioConsult operates through three integrated business units: Business & Therapy Development (BTD) provides strategic advisory and operational support covering startup management, fundraising, reimbursement strategy, CE/FDA regulatory approvals, clinical studies, and market analysis; the Innovation unit incubates early-stage healthcare concepts with internal capital and resources (portfolio projects include the MeineKlinik physician communication app and the European launch of Hawthorne Effect clinical trial follow-up services); and Commercialization leverages a core partnership with Angiopro, a DACH-region medical device distributor with 25+ years of channel experience.

The company generates revenue through project-based professional services engagements, with pricing not publicly disclosed and contracts tailored to individual client needs. Its go-to-market combines direct enterprise consulting with channel partnerships, targeting two primary customer segments: medical device companies seeking European market entry and early-stage healthcare innovation startups requiring formation, funding, and commercialization support. The firm is led by founders Hanns-Joachim Rieck (Chairman) and Benjamin Rieck (CEO), supported by a team of 11-50 employees organized into specialized verticals. AngioConsult reports 81+ completed projects and 15 client company exits over 12+ active years, though revenue figures are not publicly disclosed and the company has no external institutional funding.

Short descriptiontext

AngioConsult GmbH is a German healthcare consulting firm that guides medical device and healthcare innovation companies from concept to commercialization, specializing in cardiovascular, structural heart, and vascular surgery verticals through strategic advisory, operational support, and DACH-region distribution partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSpeyer, Germany
HQ citystring
Speyer
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device consulting, healthcare commercialization services, regulatory approval support, clinical trial management, healthcare innovation consulting
NAICS code3 codes
  • Management Consulting Services54161
  • Other Management Consulting Services541618
  • Professional, Scientific, and Technical Services54
SIC code3 codes
  • Services-Management Consulting Services8742
  • Services-Health Services8000
  • Services-Misc Health & Allied Services, Nec8090
Product category
Medical Device Consulting Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Strategic Consulting Services
TypeProfessional Services
Description

AngioConsult provides strategic advisory services including company startup support, fundraising consulting, reimbursement strategy, market research, and commercialization strategy. Services are tailored to medical device and healthcare innovation companies seeking to enter the European market.

angioconsult.de
2Operational Support Services
TypeProfessional Services
Description

The company offers operational support including European market analyses, clinical case support, marketing activities, distribution management, software implementation, and exhibitions/congresses management. These are project-based professional services supporting the full product lifecycle from market entry to commercialization.

btd.angioconsult.de
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1Business & Therapy Development
Description

Consulting unit providing strategic and operational support for therapy development from patent to commercialization, including market analysis, clinical studies, CE/FDA approvals, and reimbursement strategies.

angioconsult.de
+1 more record
Core offering1 text field

AngioConsult provides end-to-end consulting and business development services for medical device and healthcare innovation companies, spanning company formation, fundraising, regulatory approval (CE/FDA), clinical trial management, market analysis, reimbursement strategy, and commercial launch support. The firm operates three service units — Business & Therapy Development (strategic advice and operational support), the Innovation Unit (early-stage project development into commercial ventures), and Commercialization (via DACH-region distribution partner Angiopro). Services are project-based and delivered to enterprise clients in the cardiovascular, structural heart, vascular surgery, and radiology/angiology segments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 15 successful company exits achieved through their guidance and support
+2 more records
Product overview1 text field

AngioConsult is a healthcare consulting firm offering three integrated service units: (1) Business & Therapy Development (BTD) provides strategic advice and operational support for medical device commercialization, covering startup management, regulatory approval (CE/FDA), clinical studies, marketing, and distribution; (2) Innovation Unit develops early-stage healthcare concepts and software products through company founding, investment, and market validation, including the MeineKlinik communication app and Hawthorne Effect clinical trial follow-up service; (3) Commercialization through core partner Angiopro for DACH region distribution of cardiology, vascular surgery, and radiology products. The portfolio spans the full product lifecycle from concept to market launch.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Angiopro is AngioConsult's core distribution partner for the DACH region, with over 25 years of experience distributing medical devices and software products. The partnership covers cardiology, vascular surgery, and radiology/angiology specialties. Angiopro operates from angiopro.de and represents a key component of AngioConsult's go-to-market strategy, enabling clients to access established sales channels in Germany, Austria, and Switzerland.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialized healthcare strategy consulting firm focused on medtech, diagnostics, and digital health commercialization and market access—closely mirrors AngioConsult's medical device commercialization advisory offering.

TypeDirect peer
Description

Specialist life sciences consulting firm supporting biotech, medtech and digital health companies with strategy, market access, and commercialization—closely comparable boutique competitor to AngioConsult in Europe.

TypeBroad incumbent
Description

Global strategy leader with deep medtech and pharma practice supporting market entry, regulatory strategy, and commercial excellence; a major competitive incumbent to niche European medtech commercialization consultancies like AngioConsult.

TypeBroad incumbent
Description

Global management consulting firm with a substantial medtech and healthcare practice that competes for the same European market entry and commercialization mandates AngioConsult pursues.

TypeBroad incumbent
Description

Global strategy consulting firm with a large healthcare and medtech practice advising on market entry, commercial strategy, and M&A; broader portfolio of clients and capabilities than AngioConsult but addresses identical medtech commercialization decision points.

TypeBroad incumbent
Description

Global consulting leader in pricing, market access, and commercial strategy with deep healthcare and medtech practices; competes with AngioConsult on reimbursement strategy and commercialization planning for medtech innovators.

TypeDirect peer
Description

Global medtech and life sciences consulting + advisory firm that supports medical device and digital health companies across product development, regulatory, clinical, and commercialization—directly comparable to AngioConsult's BTD service stack in the European medtech space.

8ZS Associates
TypeBroad incumbent
Description

Large global consulting firm with significant European healthcare and medtech commercial strategy practice; overlaps with AngioConsult on go-to-market strategy, market access and sales/distribution advisory for medical device companies.

TypeBroad incumbent
Description

Top-tier global consultancy with healthcare and medtech teams advising on strategy, commercial launches, and post-merger integration; addresses the same medtech market access and commercialization work as AngioConsult.

10MedTech Strategic Advisors
TypeEmerging player
Description

Niche medtech-focused consultancy offering market development, commercialization strategy and partnership advisory for medical device innovators; comparable in scale and Europe-centric footprint to AngioConsult.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AngioConsult

Medical Device Consulting Servicesangioconsult.de

AngioConsult GmbH is a German healthcare consulting firm that guides medical device and healthcare innovation companies from concept to commercialization, specializing in cardiovascular, structural heart, and vascular surgery verticals through strategic advisory, operational support, and DACH-region distribution partnerships.

What AngioConsult does

AngioConsult GmbH is a privately held healthcare consulting firm headquartered in Speyer, Germany, founded in 2001. The firm specializes in guiding medical device and healthcare innovation companies from concept through commercialization, with a particular focus on the cardiovascular, structural heart, vascular surgery, and radiology/angiology verticals. AngioConsult operates through three integrated business units: Business & Therapy Development (BTD) provides strategic advisory and operational support covering startup management, fundraising, reimbursement strategy, CE/FDA regulatory approvals, clinical studies, and market analysis; the Innovation unit incubates early-stage healthcare concepts with internal capital and resources (portfolio projects include the MeineKlinik physician communication app and the European launch of Hawthorne Effect clinical trial follow-up services); and Commercialization leverages a core partnership with Angiopro, a DACH-region medical device distributor with 25+ years of channel experience.

The company generates revenue through project-based professional services engagements, with pricing not publicly disclosed and contracts tailored to individual client needs. Its go-to-market combines direct enterprise consulting with channel partnerships, targeting two primary customer segments: medical device companies seeking European market entry and early-stage healthcare innovation startups requiring formation, funding, and commercialization support. The firm is led by founders Hanns-Joachim Rieck (Chairman) and Benjamin Rieck (CEO), supported by a team of 11-50 employees organized into specialized verticals. AngioConsult reports 81+ completed projects and 15 client company exits over 12+ active years, though revenue figures are not publicly disclosed and the company has no external institutional funding.

AngioConsult firmographics

Firmographics
Name
AngioConsult
Legal name
AngioConsult GmbH
Website
https://angioconsult.de
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
11–50 employees
Short description
AngioConsult GmbH is a German healthcare consulting firm that guides medical device and healthcare innovation companies from concept to commercialization, specializing in cardiovascular, structural heart, and vascular surgery verticals through strategic advisory, operational support, and DACH-region distribution partnerships.
Ownership category
akta.pro rank

Where AngioConsult is headquartered

Location

Headquarters

HQ city
Speyer
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

AngioConsult business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Strategic Consulting Services: AngioConsult provides strategic advisory services including company startup support, fundraising consulting, reimbursement strategy, market research, and commercialization strategy. Services are tailored to medical device and healthcare innovation companies seeking to enter the European market.
  2. Operational Support Services: The company offers operational support including European market analyses, clinical case support, marketing activities, distribution management, software implementation, and exhibitions/congresses management. These are project-based professional services supporting the full product lifecycle from market entry to commercialization.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

AngioConsult product offering

Product offering

Core offering

AngioConsult provides end-to-end consulting and business development services for medical device and healthcare innovation companies, spanning company formation, fundraising, regulatory approval (CE/FDA), clinical trial management, market analysis, reimbursement strategy, and commercial launch support. The firm operates three service units — Business & Therapy Development (strategic advice and operational support), the Innovation Unit (early-stage project development into commercial ventures), and Commercialization (via DACH-region distribution partner Angiopro). Services are project-based and delivered to enterprise clients in the cardiovascular, structural heart, vascular surgery, and radiology/angiology segments.

Product overview

AngioConsult is a healthcare consulting firm offering three integrated service units: (1) Business & Therapy Development (BTD) provides strategic advice and operational support for medical device commercialization, covering startup management, regulatory approval (CE/FDA), clinical studies, marketing, and distribution; (2) Innovation Unit develops early-stage healthcare concepts and software products through company founding, investment, and market validation, including the MeineKlinik communication app and Hawthorne Effect clinical trial follow-up service; (3) Commercialization through core partner Angiopro for DACH region distribution of cardiology, vascular surgery, and radiology products. The portfolio spans the full product lifecycle from concept to market launch.

Differentiator

Problem solved

Functional benefit

Brands

  • Business & Therapy Development: Consulting unit providing strategic and operational support for therapy development from patent to commercialization, including market analysis, clinical studies, CE/FDA approvals, and reimbursement strategies.
  • Innovation

Quantifiable outcome

  • 15 successful company exits achieved through their guidance and support
  • +2 more outcomes

Companies that use AngioConsult

Customer profile

Segments3 records

Ideal customer profiles2 records

AngioConsult technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AngioConsult partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • AngioprocoreChannel Partner/ Reseller/ DistributorAngiopro is AngioConsult's core distribution partner for the DACH region, with over 25 years of experience distributing medical devices and software products. The partnership covers cardiology, vascular surgery, and radiology/angiology specialties. Angiopro operates from angiopro.de and represents a key component of AngioConsult's go-to-market strategy, enabling clients to access established sales channels in Germany, Austria, and Switzerland.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

AngioConsult competitors and assessment

Company assessment

Direct peers

  • Health Advances: Specialized healthcare strategy consulting firm focused on medtech, diagnostics, and digital health commercialization and market access—closely mirrors AngioConsult's medical device commercialization advisory offering.
  • Alacrita Consulting: Specialist life sciences consulting firm supporting biotech, medtech and digital health companies with strategy, market access, and commercialization—closely comparable boutique competitor to AngioConsult in Europe.
  • Alira Health: Global medtech and life sciences consulting + advisory firm that supports medical device and digital health companies across product development, regulatory, clinical, and commercialization—directly comparable to AngioConsult's BTD service stack in the European medtech space.

Broad incumbents

  • McKinsey & Company (Healthcare Practice): Global strategy leader with deep medtech and pharma practice supporting market entry, regulatory strategy, and commercial excellence; a major competitive incumbent to niche European medtech commercialization consultancies like AngioConsult.
  • Boston Consulting Group (Healthcare): Global management consulting firm with a substantial medtech and healthcare practice that competes for the same European market entry and commercialization mandates AngioConsult pursues.
  • L.E.K. Consulting: Global strategy consulting firm with a large healthcare and medtech practice advising on market entry, commercial strategy, and M&A; broader portfolio of clients and capabilities than AngioConsult but addresses identical medtech commercialization decision points.
  • Simon-Kucher & Partners: Global consulting leader in pricing, market access, and commercial strategy with deep healthcare and medtech practices; competes with AngioConsult on reimbursement strategy and commercialization planning for medtech innovators.
  • ZS Associates: Large global consulting firm with significant European healthcare and medtech commercial strategy practice; overlaps with AngioConsult on go-to-market strategy, market access and sales/distribution advisory for medical device companies.
  • Bain & Company (Healthcare): Top-tier global consultancy with healthcare and medtech teams advising on strategy, commercial launches, and post-merger integration; addresses the same medtech market access and commercialization work as AngioConsult.

Emerging players

  • MedTech Strategic Advisors: Niche medtech-focused consultancy offering market development, commercialization strategy and partnership advisory for medical device innovators; comparable in scale and Europe-centric footprint to AngioConsult.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

AngioConsult social profiles

Digital presence

AngioConsult financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AngioConsult leadership team

Management profile

Number of profiles

Profiles10 records

AngioConsult funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AngioConsult M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AngioConsult

What does AngioConsult do?

AngioConsult provides end-to-end consulting and business development services for medical device and healthcare innovation companies, spanning company formation, fundraising, regulatory approval (CE/FDA), clinical trial management, market analysis, reimbursement strategy, and commercial launch support. The firm operates three service units — Business & Therapy Development (strategic advice and operational support), the Innovation Unit (early-stage project development into commercial ventures), and Commercialization (via DACH-region distribution partner Angiopro). Services are project-based and delivered to enterprise clients in the cardiovascular, structural heart, vascular surgery, and radiology/angiology segments.

Is AngioConsult a public or private company?

AngioConsult is a private company. It is classified as family owned and is currently operating.

When was AngioConsult founded?

AngioConsult was founded in 2001. It employs 11 to 50 people.

Where is AngioConsult based?

AngioConsult is headquartered in Speyer, Germany, in the Europe region.

How does AngioConsult make money?

Two revenue lines are on record. Strategic Consulting Services are the primary driver. The others are operational Support Services.

Who are AngioConsult's main competitors?

Direct peers on record are Health Advances, Alacrita Consulting and Alira Health. Broad incumbents are McKinsey & Company (Healthcare Practice), Boston Consulting Group (Healthcare), L.E.K. Consulting, Simon-Kucher & Partners, ZS Associates and Bain & Company (Healthcare). MedTech Strategic Advisors is listed as an emerging player.

Does AngioConsult have an API?

No public API is recorded for AngioConsult.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales